These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 26600329)
1. Thyroid profile status of patients treated for multidrug-resistant tuberculosis in state of Meghalaya, India. Saharia GK; Ruram AA; Lyngwa J Indian J Tuberc; 2015 Jul; 62(3):166-70. PubMed ID: 26600329 [TBL] [Abstract][Full Text] [Related]
2. Home based care to multi-drug resistant tuberculosis patients: A pilot study. Vaghela JF; Kapoor SK; Kumar A; Dass RT; Khanna A; Bhatnagar AK Indian J Tuberc; 2015 Apr; 62(2):91-6. PubMed ID: 26117478 [TBL] [Abstract][Full Text] [Related]
3. High rate of hypothyroidism among patients treated for multidrug-resistant tuberculosis in Lesotho. Satti H; Mafukidze A; Jooste PL; McLaughlin MM; Farmer PE; Seung KJ Int J Tuberc Lung Dis; 2012 Apr; 16(4):468-72. PubMed ID: 22326109 [TBL] [Abstract][Full Text] [Related]
4. Thyroid function in multidrug-resistant tuberculosis patients with or without human immunodeficiency virus (HIV) infection before commencement of MDR-TB drug regimen. Ige OM; Akinlade KS; Rahamon SK; Edem VF; Arinola OG Afr Health Sci; 2016 Jun; 16(2):596-602. PubMed ID: 27605977 [TBL] [Abstract][Full Text] [Related]
5. Treatment outcome among cases of multidrug-resistant tuberculosis (MDR TB) in Western India: A prospective study. Patel SV; Nimavat KB; Alpesh PB; Shukla LK; Shringarpure KS; Mehta KG; Joshi CC J Infect Public Health; 2016; 9(4):478-84. PubMed ID: 26724262 [TBL] [Abstract][Full Text] [Related]
6. Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan. Chien JY; Lai CC; Tan CK; Chien ST; Yu CJ; Hsueh PR J Antimicrob Chemother; 2013 Aug; 68(8):1910-6. PubMed ID: 23580558 [TBL] [Abstract][Full Text] [Related]
7. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China. Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894 [TBL] [Abstract][Full Text] [Related]
8. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns. Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562 [TBL] [Abstract][Full Text] [Related]
9. [Impact of anti-tuberculosis drug resistance on treatment outcome of pulmonary tuberculosis patients receiving directly observed treatment strategy in Henan Province, China]. Wang GJ; Xu JY; Wang GB; Zhen XA; Gao SY; Du CM Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):527-30. PubMed ID: 17074265 [TBL] [Abstract][Full Text] [Related]
10. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases. Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008 [TBL] [Abstract][Full Text] [Related]
11. An epidemiological study of multi drug resistant tuberculosis cases registered under Revised National Tuberculosis Control Programme of Ahmedabad City. Bhatt G; Vyas S; Trivedil K Indian J Tuberc; 2012 Jan; 59(1):18-27. PubMed ID: 22670507 [TBL] [Abstract][Full Text] [Related]
12. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India. Aparna SB; Reddy VC; Gokhale S; Moorthy KV Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801 [TBL] [Abstract][Full Text] [Related]
13. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism]. Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study. Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741 [TBL] [Abstract][Full Text] [Related]
16. Changing patterns and trends of multidrug-resistant tuberculosis at referral centre in Northern India: a 4-year experience. Maurya AK; Singh AK; Kumar M; Umrao J; Kant S; Nag VL; Kushwaha RA; Dhole TN Indian J Med Microbiol; 2013; 31(1):40-6. PubMed ID: 23508428 [TBL] [Abstract][Full Text] [Related]
17. DOTS-Plus for multidrug-resistant tuberculosis in the Philippines: global assistance urgently needed. Tupasi TE; Quelapio MI; Orillaza RB; Alcantara C; Mira NR; Abeleda MR; Belen VT; Arnisto NM; Rivera AB; Grimaldo ER; Derilo JO; Dimarucut W; Arabit M; Urboda D Tuberculosis (Edinb); 2003; 83(1-3):52-8. PubMed ID: 12758189 [TBL] [Abstract][Full Text] [Related]
18. [Multidrug resistant tuberculosis in Romania in the last years (2004-2007)--an extremely important social phenomenon]. Marica C; Didilescu C; Chiotan D; Galie N; Tănăsescu M; Popescu-Hagen M; Popa M Pneumologia; 2008; 57(4):195-200. PubMed ID: 19186681 [TBL] [Abstract][Full Text] [Related]
19. Screening outcomes from patients with suspected multidrug-resistant tuberculosis: lessons learned in the Philippines. Gler MT; Guilatco RS; Guray CV; Tupasi TE Int J Tuberc Lung Dis; 2012 Oct; 16(10):1326-30. PubMed ID: 22863522 [TBL] [Abstract][Full Text] [Related]
20. Tuberculosis among household contacts of multidrug-resistant tuberculosis patients in Delhi, India. Singla N; Singla R; Jain G; Habib L; Behera D Int J Tuberc Lung Dis; 2011 Oct; 15(10):1326-30. PubMed ID: 22283889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]